Encompass Health Corporation logo

Encompass Health Corporation (EHC)

Market Closed
22 Jul, 20:00
NYSE NYSE
$
111. 02
-1.08
-0.9634%
$
11.13B Market Cap
22.2 P/E Ratio
0.68% Div Yield
517,150 Volume
3.97 Eps
$ 112.1
Previous Close
Add Transaction
Day Range
110.23 113.43
Year Range
92.77 127.99
Want to track EHC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term

Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
Encompass Health Opens 9th Hospital in SC: More in the Pipeline?

Encompass Health Opens 9th Hospital in SC: More in the Pipeline?

This new facility is part of EHC's continued strategy to meet the rising demand for rehabilitative services.

Zacks | 1 year ago
Here's Why Encompass Health (EHC) is a Strong Momentum Stock

Here's Why Encompass Health (EHC) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Encompass Health Stock Rises 39.4% YTD: Should You Buy Now?

Encompass Health Stock Rises 39.4% YTD: Should You Buy Now?

To meet the increasing demand for its services, EHC is expected to continue adding beds.

Zacks | 1 year ago
All You Need to Know About Encompass Health (EHC) Rating Upgrade to Buy

All You Need to Know About Encompass Health (EHC) Rating Upgrade to Buy

Encompass Health (EHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks | 1 year ago
Here's Why Encompass Health (EHC) is a Strong Momentum Stock

Here's Why Encompass Health (EHC) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
Here's Why Encompass Health (EHC) is a Strong Value Stock

Here's Why Encompass Health (EHC) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Encompass Health (EHC) is a Top-Ranked Growth Stock: Should You Buy?

Encompass Health (EHC) is a Top-Ranked Growth Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Encompass Health (EHC) Stock Down 6% Despite Q2 Earnings Beat

Encompass Health (EHC) Stock Down 6% Despite Q2 Earnings Beat

Encompass Health's (EHC) Q2 results reflect improved net patient revenue per discharge, partly offset by higher costs. It currently estimates 2024 adjusted EPS within $3.97-$4.22, up from the earlier view of $3.86-$4.11.

Zacks | 1 year ago
Encompass Health (EHC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Encompass Health (EHC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Encompass Health (EHC) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 1 year ago
Encompass Health (EHC) Q2 Earnings Beat Estimates

Encompass Health (EHC) Q2 Earnings Beat Estimates

Encompass Health (EHC) came out with quarterly earnings of $1.11 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $0.95 per share a year ago.

Zacks | 1 year ago
Unlocking Q2 Potential of Encompass Health (EHC): Exploring Wall Street Estimates for Key Metrics

Unlocking Q2 Potential of Encompass Health (EHC): Exploring Wall Street Estimates for Key Metrics

Evaluate the expected performance of Encompass Health (EHC) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks | 1 year ago
Loading...
Load More